Reunion Neuroscience Inc.
Share · CA76134G1037 · REUN (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Reunion Neuroscience Inc.
No Price
Company Profile for Reunion Neuroscience Inc. Share
Field Trip Health Ltd. engages in the development and delivery of psychedelic- assisted therapies in North America. The company operates Field Trip Health Centres that provide psychedelic therapies; offers Field Trip Digital apps; operates Field Trip Discovery, a drug development division that develops the next generation of psychedelic molecules; and provides ketamine-assisted therapy for the treatment of depression, anxiety, addiction, and other conditions. Field Trip Health Ltd. was founded in 2008 and is headquartered in Toronto, Canada.
Company Data
Name Reunion Neuroscience Inc.
Company Reunion Neuroscience Inc.
Symbol REUN
Website
https://www.fieldtriphealth.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN CA76134G1037
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Gregory T. Mayes
Market Capitalization 13 Mio
Country Canada
Currency USD
Employees 0,0 T
Address 30 Duncan Street, M5V 2C3 Toronto
IPO Date 2020-10-07
Stock Splits
| Date | Split |
|---|---|
| 17.08.2022 | 1:5 |
ID Changes
| Date | From | To |
|---|---|---|
| 17.08.2022 | FTRP | REUN |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | REUN |
More Shares
Investors who hold Reunion Neuroscience Inc. also have the following shares in their portfolio:
